Phase I dose‐escalation trial of Sym004, an anti‐EGFR antibody mixture, in Japanese patients with advanced solid tumors

Yazar: Kojima, Takashi, Yamazaki, Kentaro, Kato, Ken, Muro, Kei, Hara, Hiroki, Chin, Keisho, Goddemeier, Thomas, Kuffel, Stefan, Watanabe, Morihiro, Doi, Toshihiko
Yayımlandı Cancer Sci (2018)